Literature DB >> 21572308

Decreased limb muscle and increased central adiposity are associated with 5-year all-cause mortality in HIV infection.

Rebecca Scherzer1, Steven B Heymsfield, Daniel Lee, William G Powderly, Phyllis C Tien, Peter Bacchetti, Michael G Shlipak, Carl Grunfeld.   

Abstract

BACKGROUND: Unintentional loss of weight and muscle due to aging and disease has been associated with increased mortality. Wasting and weight loss occur in HIV infection even in the modern era of effective antiretroviral therapy.
METHODS: We determined the association of MRI-measured regional and total skeletal muscle and adipose tissue with 5-year, all-cause mortality in 922 HIV-infected persons in the study of Fat Redistribution and Metabolic Change in HIV Infection (FRAM).
RESULTS: After 5 years of follow-up, HIV-infected participants with arm skeletal muscle in the lowest tertile had a mortality rate of 23%, compared with 11 and 8% for those in the middle and highest tertiles. After multivariable adjustment for demographics, cardiovascular risk factors, HIV-related factors, inflammatory markers, and renal disease, we found that lower arm skeletal muscle, lower leg skeletal muscle and higher visceral adipose tissue (VAT) were each independently associated with increased mortality. Those in the lowest tertile of arm or leg skeletal muscle had higher odds of death [arm: odds ratio (OR) = 2.0, 95% confidence interval (CI) 0.96-4.0; leg: OR = 2.4, 95% CI 1.2-4.8] compared with the highest respective tertiles. Those in the highest tertile of VAT had 2.1-fold higher odds of death (95% CI 1.1-4.0) compared with the lowest VAT tertile.
CONCLUSION: Lower muscle mass and central adiposity appear to be important risk factors for mortality in HIV-infected individuals. A substantial proportion of this risk may be unrecognized because of the current reliance on body mass index in clinical practice.

Entities:  

Mesh:

Year:  2011        PMID: 21572308      PMCID: PMC3933309          DOI: 10.1097/QAD.0b013e32834884e6

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  33 in total

1.  Midarm muscle circumference, physical performance and mortality: results from the aging and longevity study in the Sirente geographic area (ilSIRENTE study).

Authors:  Francesco Landi; Andrea Russo; Rosa Liperoti; Marco Pahor; Matteo Tosato; Ettore Capoluongo; Roberto Bernabei; Graziano Onder
Journal:  Clin Nutr       Date:  2010-02-08       Impact factor: 7.324

2.  Regional adipose tissue measured by MRI over 5 years in HIV-infected and control participants indicates persistence of HIV-associated lipoatrophy.

Authors:  Carl Grunfeld; Michael Saag; Joseph Cofrancesco; Cora Elizabeth Lewis; Richard Kronmal; Steven Heymsfield; Phyllis C Tien; Peter Bacchetti; Michael Shlipak; Rebecca Scherzer
Journal:  AIDS       Date:  2010-07-17       Impact factor: 4.177

3.  Body mass index and risk of tuberculosis and death.

Authors:  Colleen F Hanrahan; Jonathan E Golub; Lerato Mohapi; Nkeko Tshabangu; Tebogo Modisenyane; Richard E Chaisson; Glenda E Gray; James A McIntyre; Neil A Martinson
Journal:  AIDS       Date:  2010-06-19       Impact factor: 4.177

4.  Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV.

Authors:  Jacqueline Neuhaus; Brian Angus; Justyna D Kowalska; Alberto La Rosa; Jim Sampson; Deborah Wentworth; Amanda Mocroft
Journal:  AIDS       Date:  2010-03-13       Impact factor: 4.177

5.  Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort.

Authors:  Phyllis C Tien; Andy I Choi; Andrew R Zolopa; Constance Benson; Russell Tracy; Rebecca Scherzer; Peter Bacchetti; Michael Shlipak; Carl Grunfeld
Journal:  J Acquir Immune Defic Syndr       Date:  2010-11       Impact factor: 3.731

6.  Rapid loss of appendicular skeletal muscle mass is associated with higher all-cause mortality in older men: the prospective MINOS study.

Authors:  Pawel Szulc; Françoise Munoz; François Marchand; Roland Chapurlat; Pierre D Delmas
Journal:  Am J Clin Nutr       Date:  2010-03-17       Impact factor: 7.045

7.  Waist circumference and all-cause mortality in a large US cohort.

Authors:  Eric J Jacobs; Christina C Newton; Yiting Wang; Alpa V Patel; Marjorie L McCullough; Peter T Campbell; Michael J Thun; Susan M Gapstur
Journal:  Arch Intern Med       Date:  2010-08-09

8.  Association of HIV infection, demographic and cardiovascular risk factors with all-cause mortality in the recent HAART era.

Authors:  Leslie Cockerham; Rebecca Scherzer; Andrew Zolopa; David Rimland; Cora E Lewis; Peter Bacchetti; Carl Grunfeld; Michael Shlipak; Phyllis C Tien
Journal:  J Acquir Immune Defic Syndr       Date:  2010-01       Impact factor: 3.731

9.  Influence of central and extremity circumferences on all-cause mortality in men and women.

Authors:  Caitlin Mason; Cora L Craig; Peter T Katzmarzyk
Journal:  Obesity (Silver Spring)       Date:  2008-10-16       Impact factor: 5.002

10.  Patterns of abdominal fat distribution: the Framingham Heart Study.

Authors:  Karla M Pou; Joseph M Massaro; Udo Hoffmann; Kathrin Lieb; Ramachandran S Vasan; Christopher J O'Donnell; Caroline S Fox
Journal:  Diabetes Care       Date:  2008-12-15       Impact factor: 19.112

View more
  51 in total

1.  Cardiovascular disease in HIV: traditional and nontraditional risk factors.

Authors:  Steven K Grinspoon
Journal:  Top Antivir Med       Date:  2014 Sep-Oct

Review 2.  Management of the metabolic effects of HIV and HIV drugs.

Authors:  Todd T Brown; Marshall J Glesby
Journal:  Nat Rev Endocrinol       Date:  2011-09-20       Impact factor: 43.330

Review 3.  Endocrinological aspects of HIV infection.

Authors:  F S Mirza; P Luthra; L Chirch
Journal:  J Endocrinol Invest       Date:  2018-01-08       Impact factor: 4.256

4.  Weight and lean body mass change with antiretroviral initiation and impact on bone mineral density.

Authors:  Kristine M Erlandson; Douglas Kitch; Camlin Tierney; Paul E Sax; Eric S Daar; Pablo Tebas; Kathleen Melbourne; Belinda Ha; Nasreen C Jahed; Grace A McComsey
Journal:  AIDS       Date:  2013-08-24       Impact factor: 4.177

5.  Association between chronic hepatitis C virus infection and low muscle mass in US adults.

Authors:  C Gowda; C Compher; V K Amorosa; V Lo Re
Journal:  J Viral Hepat       Date:  2014-07-02       Impact factor: 3.728

6.  The association of adiposity with kidney function decline among HIV-infected adults: findings from the Fat Redistribution and Metabolic Changes in HIV Infection (FRAM) study.

Authors:  A Malkina; R Scherzer; M G Shlipak; P Bacchetti; P C Tien; C Grunfeld; L Kosmiski; C A Peralta
Journal:  HIV Med       Date:  2014-09-23       Impact factor: 3.180

7.  Prevalence and predictors of low muscle mass in HIV/viral hepatitis coinfection.

Authors:  Charitha Gowda; Todd T Brown; Charlene Compher; Kimberly A Forde; Jay Kostman; Pamela A Shaw; Phyllis C Tien; Vincent Lo Re
Journal:  AIDS       Date:  2016-10-23       Impact factor: 4.177

8.  Comparison of body composition changes between atazanavir/ritonavir and lopinavir/ritonavir each in combination with tenofovir/emtricitabine in antiretroviral-naïve patients with HIV-1 infection.

Authors:  Graeme J Moyle; Hélène Hardy; Awny Farajallah; Michelle DeGrosky; Donnie McGrath
Journal:  Clin Drug Investig       Date:  2014-04       Impact factor: 2.859

9.  Long-term body composition changes in antiretroviral-treated HIV-infected individuals.

Authors:  Philip M Grant; Douglas Kitch; Grace A McComsey; Ann C Collier; Benedetta Bartali; Susan L Koletar; Kristine M Erlandson; Jordan E Lake; Michael T Yin; Kathy Melbourne; Belinda Ha; Todd T Brown
Journal:  AIDS       Date:  2016-11-28       Impact factor: 4.177

Review 10.  Disease drivers of aging.

Authors:  Richard J Hodes; Felipe Sierra; Steven N Austad; Elissa Epel; Gretchen N Neigh; Kristine M Erlandson; Marissa J Schafer; Nathan K LeBrasseur; Christopher Wiley; Judith Campisi; Mary E Sehl; Rosario Scalia; Satoru Eguchi; Balakuntalam S Kasinath; Jeffrey B Halter; Harvey Jay Cohen; Wendy Demark-Wahnefried; Tim A Ahles; Nir Barzilai; Arti Hurria; Peter W Hunt
Journal:  Ann N Y Acad Sci       Date:  2016-12       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.